期刊文献+

健脾消癌方治疗晚期结直肠癌Ⅳ期脾虚瘀毒证30例 被引量:2

Clinical effect of Jianpi Xiaoai prescription in treatment of stage IV advanced colorectal cancer with syndrome of spleen deficiency and stasis toxin:An analysis of 30 cases
原文传递
导出
摘要 目的:观察健脾消癌方治疗结直肠癌Ⅳ期脾虚瘀毒证的临床疗效。方法:将60例结直肠癌Ⅳ期脾虚瘀毒证患者随机分为治疗组与对照组,每组各30例。对照组采用mFOLFOX6方案行全身化疗,治疗组在对照组基础上联合中药汤剂健脾消癌方口服治疗。比较2组治疗前后Karnofsky功能状态(KPS)评分、肿瘤标志物[血清癌胚抗原(CEA)、糖类抗原199(CA199)]水平、免疫功能指标水平及中医证候积分,评定中医证候疗效。结果:中医证候疗效总有效率治疗组为83.33%(25/30),对照组为60.00%(18/30),2组差异有统计学意义(P<0.05);与治疗前比较,治疗后2组KPS评分均提高,CEA和CAl99水平、中医证候积分均降低,免疫功能相关指标水平均升高,且治疗组均优于对照组,差异均有统计学意义(P<0.05)。结论:基于扶正消积法拟定的健脾消癌方可有效提高结直肠癌Ⅳ期脾虚瘀毒证患者的生活质量及免疫功能,并改善患者中医临床症状,降低肿瘤标志物水平,具有较好的推广价值。 Objective:To investigate the clinical effect of Jianpi Xiaoai prescription in the treatment of stage IV advanced colorectal cancer with syndrome of spleen deficiency and stasis toxin.Methods:A total of 60 patients with stage IV advanced colorectal cancer with spleen deficiency and stasis toxin were randomly divided into treatment group and control group,with 30 patients in each group.The patients in the control group received systemic chemotherapy with the mFOLFOX6 regimen,and those in the treatment group received oral administration of the traditional Chinese medicine(TCM)decoction Jianpi Xiaoai prescription in addition to the treatment in the control group.The two groups were compared in terms of Karnofsky Performance Scale(KPS)score,tumor markers[serum carcinoembryonic antigen(CEA)and carbohydrate antigen 199(CA199)],immune function parameters,and TCM syndrome score,and the treatment outcome of TCM syndrome was evaluated.Results:There was a significant diffe rence in the overall response rate of TCM syndrome between the treatment group and the control group[83.33%(25/30)vs 60.00%(18/30),P<0.05].After treatment,both groups had a significant increase in KPS score,significant reductions in CEA,CA199,and TCM syndrome,and significant increases in immune function parameters,and the treatment group had significantly better indicators than the control group(P<0.05).Conclusion:In the treatment of patients with stage IV advanced colorectal cancer with spleen deficiency and stasis toxin,Jianpi Xiaoai prescription developed based on the method of strengthening vital Qi and removing food retention can effectively improve quality of life and immune function,alleviate TCM clinical symptoms,and reduce the levels of tumor markers,and therefore,it holds promise for clinical application.
作者 赵晔 蒋益兰 吴红玉 唐婕妤 俞天俊 ZHAO Ye;JIANG Yilan;WU Hongyu;TANG Jieyu;YU Tianjun(The Affiliated Hospital of Hunan Academy of Chinese Medicine,Changsha 410006,Hunan,China)
出处 《湖南中医杂志》 2023年第9期5-8,共4页 Hunan Journal of Traditional Chinese Medicine
基金 湖南省自然科学基金青年基金项目(2020JJ5329) 湖南省中医药科研计划重点项目(A2023042)。
关键词 结直肠癌 Ⅳ期 脾虚瘀毒证 健脾消癌方 扶正消积 colorectal cancer stage IV syndrome of spleen deficiency and stasis toxin Jianpi Xiaoai prescription strengthening vital Qi and removing food retention
  • 相关文献

参考文献6

二级参考文献21

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1568
  • 2中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范[M].2版.北京:北京医科大学中国协和医科大学联合出版社,1991:2-3. 被引量:20
  • 3上海市疾病预防控制中心.2010年上海市恶性肿瘤报告[R].上海:上海市疾病预防控制中心,2010. 被引量:2
  • 4格林尼,佩基,弗莱明,等.AJCC癌症分期手册[M].沈阳辽宁科学技术出版社,2005:113-116. 被引量:1
  • 5沈小珩,周菲.《伤寒杂病论》对中医治疗肿瘤的临床指导意义[J].上海中医药杂志,2007,41(12):47-50. 被引量:4
  • 6Roh SA, Choi EY, Cho DH, et al. Characterization of biologi-cal responses of colorectal cancer cells to anticancer regimens [ J ]. J Korean Surg Soc,2012,83 ( 1 ) : 21 - 29. 被引量:1
  • 7Wenhao Weng, Junlan Feng, Huanlong Qin, et al. Molecular therapy of colorectal cancer : Progress and future directions [ J ]. International Journal of Cancer, 2015,136 (3) :493 - 502. 被引量:1
  • 8Caroline Coghlin, Graeme I. Murray. Biomarkers of colorec- tal cancer: Recent advances and future challenges [ J ]. Pro- teomics Clinical Applications, 2015,9 ( 1 ) :64 - 71. 被引量:1
  • 9Power DG, Asmis TR, Tang LH, et al. High - grade neuro- endocrine carcinoma of the colon,long - term survival in ad- vanced disease[ J ]. Med, Oncol,2011,28 ( 1 ) : 169 - 174. 被引量:1
  • 10成玲玲,许建华.中医药治疗晚期结直肠癌的临床研究进展[J].环球中医药,2012,5(4):314-317. 被引量:13

共引文献440

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部